Doktorlar

DR.ÖĞR.ÜYESİ GÜRKAN GÜNER

DR.ÖĞR.ÜYESİ GÜRKAN GÜNER

Doktor Bilgileri

Eğitim ve Uzmanlık

  • İSTANBUL ATATÜRK FEN LİSESİ
  • TIP EĞİTİMİ - HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ
  • İÇ HASTALIKLARI UZMANLIĞI - HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ, İÇ HASTALIKLARI ABD
  • TIBBİ ONKOLOJİ UZMANLIĞI - HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ, TIBBİ ONKOLOJİ BD

Hastalıklar

  • Akciğer Kanseri
  • Meme Kanseri
  • Diğer Kanserler
  • Baş Boyun Tümörleri
  • Beyin Tümörleri
  • Gastrointestinal Kanserler
  • Genitoüriner Kanserler
  • Jinekolojik Kanserler
  • Sarkomlar
  • Lenfoma
  • Malign Melanoma

Tedavi Yöntemleri

  • Kemoterapi
  • İmmünoterapi
  • Bireysel Tedaviler (Kapsamlı Genomik Profilleme)
  • Akıllı İlaç Uygulamaları
  • Kemoimmunoterapi

Deneyim

  • Hacettepe Üniversitesi Hastanesi İç Hastalıkları
  • Hacettepe Üniversitesi Hastanesi Tıbbi Onkoloji
  • Van Eğitim ve Araştırma Hastanesi Tıbbi Onkoloji

Mesleki Üyelikleri

  • Türk Tıbbi Onkoloji Derneği
  • European Society for Medical Oncology (ESMO)
  • American Society of Clinical Oncology (ASCO)
  • İzmir Tabip Odası

Araştırma Yayınları

  • Güner, G.; Aktaş, B.Y.; Başal, F.B.; Demirkazık, A.; Gürsoy, P.; Demirci, U.; Erman, M.; Yumuk, P.F.; Şenler, F.; Çakar, B.; et al. Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC? J Cancer Res Clin Oncol 2023, doi:10.1007/s00432-023-05190-3.

 

  • Muslih Ürün; Gürkan Güner; Yasin Sezgi̇n; Emre Uysal; Yonca Yilmaz Ürün; Abdullah Saki̇n. Comparison of the Efficacy of FOLFIRI and Paclitaxel Chemotherapy Regimens in the Second Line Treatment of Metastatic Gastric Cancer. Van Sağlık Bilimleri Dergisi2023.

 

  • Demir M, Güven D, Aktaş BY, Güner G, Aktepe OH, Taban H, et al. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience. South Asian journal of cancer. 2022;11(4):287-92. Doi: 10.1055/s-0042-1755467.

 

  • Yildirim H, Guven D, Aktepe O, Taban H, Yilmaz F, Yasar S, Aktaş BY, Güner G et al. Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy. EJMO. 2022; 6(1): 59-63. Doi: 10.14744/ejmo.2022.78280.

 

  • Guven DC, Aktepe OH, Aksun MS, Sahin TK, Kavgaci G, Ucgul E, Cakir IY, Yildirim HC, Guner G, Akin S, Kertmen N, Dizdar O, Aksoy S, Erman M, Yalcin S, Kilickap S. The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors. Cancer biomarkers : section A of Disease markers. 2022;34(2):189-99. Doi: 10.3233/cbm-210349.

 

  • Aktepe OH, Sahin TK, Guner G, Guven DC, Yeter HH et al. Correlation Between THSD7A Expression and Tumor Characteristics of Azoxymethane-Induced Colon Cancer Model in Rats. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2021; 32 (12): 1049-1056. Doi: 10.5152/tjg.2021.20899.

 

  • Halit Aktepe O, Sinem Ardic F, Yuce D, Can Guven D, Guner G et al. Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better? Journal of BUON : official journal of the Balkan Union of Oncology 2021; 26 (5): 2067-2073.

 

  • Bas O, Erdemir AG, Onur MR, Ozer N, Sener YZ, Aksu S, Barista I, Guner G, Guven DC, Kertmen N, Aksoy S, Turker A, Dizdar O. Sarcopenia and anthracycline cardiotoxicity in patients with cancer. BMJ supportive & palliative care. 2021. Epub 2021/09/05. Doi: 10.1136/bmjspcare-2021-003197.

 

  • Bilgin B, Şendur MAN, Yücel Ş, Hizal M, Güner G, Akyürek N, et al. The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement. Journal of cancer research and clinical oncology. 2021;147(9):2637-43. Doi: 10.1007/s00432-021-03546-1.

 

  • Guven DC, Aktepe OH, Taban H, Aktas BY, Guner G, Yildirim HC, et al. Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors. Biomarkers in medicine. 2021;15(13):1123-30. Doi: 10.2217/bmm-2020-0674.

 

  • Guven DC, Ceylan F, Cakir IY, Cesmeci E, Sayinalp B, Yesilyurt B, Guner G, Yildirim HC, Aktepe OH, Arik Z, Turker A, Dizdar O. Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021;29(7):4159-64. Doi: 10.1007/s00520-020-05927-7.

 

  • Aktepe OH, Güner G, Güven DC, Taban H, Yıldırım H, Şahin TK, et al. Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma. Turkish journal of urology. 2021;47(2):113-9. Doi: 10.5152/tud.2021.20377.

 

  • Aktepe OH, Güner G, Güven DC, Şahin TK, Ardıç FS, Yüce D, et al. The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma. Turkish journal of medical sciences. 2021;51(2):757-65. Doi: 10.3906/sag-2009-75.

 

  • Aktepe OH, Şahin TK, Güner G, Arik Z, Yalçin Ş. Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway. Turkish journal of medical sciences. 2021;51(1):368-74. Doi: 10.3906/sag-2005-413.

 

  • Guven DC, Aktas BY, Aksun MS, Ucgul E, Sahin TK, Yildirim HC, Guner G, Kertmen N, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Turker A, Uckun FM, Arik Z. COVID-19 pandemic: changes in cancer admissions. BMJ supportive & palliative care. 2020. Doi: 10.1136/bmjspcare-2020-002468.

 

  • Guven DC, Guner G, Aktas BY, Aktepe OH, Taban H, Arik Z. Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design. Clinical colorectal cancer. 2020;19(3):e71-e2. Doi: 10.1016/j.clcc.2020.02.011.

 

  • Varan HD, Kılıç MK, Kızılarslanoğlu MC, Tuna Doğrul R, Arık G, Kara Ö, Güner G, Şengül Ayçiçek G, Can B, Halil M, Cankurtaran M, Yavuz BB. Frailty and its Correlates in Older Adults: A Challenging and Preventable Geriatric Syndrome. Erciyes Med J. 2020;42(2):150-6. Doi: 10.14744/etd.2019.26504.

 

  • Guven DC, Kilickap S, Guner G, Taban H, Dizdar O. Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2020;26(1):256-8. Doi: 10.1177/1078155219877234.

 

  • Aktas BY, Guner G, Guven DC, Arslan C, Dizdar O. Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy. Expert Review of Anticancer Therapy 2019; 19 (7): 589-601. Doi: 10.1080/14737140.2019.1631162.

 

  • Dizdar O, Guven DC, Guner G, Erman M, Hayran M. Gleason score and docetaxel response in advanced hormone-sensitive prostate cancer: The lower the better. Journal of Oncological Sciences 2019; 5 (2): 45-48. Doi: https://doi.org/10.1016/j.jons.2019.06.001.

 

  • Guner G, Dizdar O. Glucocorticoids in breast cancer treatment: real benefit or selection bias? Breast cancer research and treatment. 2018;172(1):243. Doi: 1007/s10549-018-4871-2.

 

  • Varan HD, Guner G, Kizilarslanoglu MC, et al. Higher Serum Endocan Level Is Associated with Alzheimer Disease. Dementia and geriatric cognitive disorders. 2018;44(5-6):303-310. Doi: 1159/000485245.